Home » Newsletters » BioWorld Science

BioWorld Science

April 1, 1999

View Archived Issues

Aurora and Becton Dickinson announce drug development agreement

Procept receives additional patent allowances for PRO-2000

MGI Pharma to promote Ridaura and Luxiq for Connetics

DSMB completes interim evaluation of Maxamine phase III clinical trials

SciClone receives another approval for Zadaxin

Inflazyme lays plans for phase I testing of IPL-576092

Aquila initiates phase IIb testing of Quilimmune-P

New microbially produced inhibitor of HSP expression in development at Mercian

Temporary platelet inhibition by SM-20302 results in sustained antithrombotic efficacy in dog model

Xenova: year-end 1998 highlights

New microtubule-stabilizing agents developed at Schering

Dopaminergic agents for anxiety, depression and Parkinson's disease disclosed by ADIR

Merck & Co. presents new macrolide immunosuppressants

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

More from ACS meeting: Pfizer presents potent new leukotriene antagonists with oral activity

New antimuscarinic piperidine derivative from Taisho inhibits bladder contractions

Dihydropyridines for reversing MDR presented at Japanese scientific meeting this week

Selective N-type VACC blockers under investigation at Warner-Lambert and Elan

First regulatory approval sought for Reminyl for Alzheimer's disease

Aronex regains worldwide marketing rights to Atragen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...